Lee Hood's $200 Million Project, Setting Microarray Standards, Academia and Industry Teaming Up | GenomeWeb

Ten years ago this month, the first issue of Genome Technology hit mailboxes. In their letter to readers, chairman Dennis Waters and publisher Harry Greenwald said it was a good time for a new magazine focused on the "technology-led culture change in life sciences research" to launch, and that GT would be "dedicated to documenting and illuminating that change for the people who are living through it and living in it." How fitting, then, that GT's first cover story focused on Leroy Hood's $200 million institution for what was then being called "the new biology."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.